Odense, Denmark, 2 February 2009. Proxeon A/S (Proxeon) today announced that it has successfully completed a capital increase of DKK 14 Million. The investment was made by current venture capital investors as well as several members of the board. The proceeds, which are expected to be sufficient to reach positive cash flow, will be used […]
Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced the preliminary results of elections made by Applied Biosystems stockholders regarding their preferences as to the form of merger consideration they will receive in the pending acquisition of Applied Biosystems by Invitrogen. The election deadline for Applied Biosystems stockholders to have made merger consideration elections […]
Invitrogen Corporation (NASDAQ:IVGN) today announced that the syndication of the financing relating to its proposed acquisition of Applied Biosystems announced on June 12, 2008 has been completed. Pricing for the $2.65 billion financing was in line with expected terms. The Term Loan A, in the amount of $1.4 billion, and the Revolving Credit Facility, in […]
Invitrogen Provides Update on Regulatory Review and Financing for the Applied Biosystems Acquisition
Invitrogen Corporation (NASDAQ: IVGN) today provided the following updates on regulatory and financing relating to the proposed acquisition of Applied Biosystems announced on June 12, 2008. Regulatory As previously announced on July 29th, the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) has expired in connection with the proposed acquisition. The expiration […]
PENZBERG, Germany–Roche Applied Science announced the start of the Roche Prime Supply Program today. Prime Supply is an on-site stocking program ensuring immediate availability of Roche Applied Science products. This system provides efficient and economical access to consignment stock stored on site at your facility, avoiding supply and delivery issues and reducing delays in your […]
Services Expand Refiners Capabilities in Catalyst Discovery and Development and Reduce Pilot Plant Runs Symyx Technologies, Inc. (SMMX – News) announced today, at the opening of the 14th Annual International Congress of Catalysis, the expansion of Symyx Research to include Refining R&D services. Symyx is showcasing its capabilities at the International Congress on Catalysis in […]
Led by Medical Scientific Advisory Board of Leading Scientists and Physicians Institute Will Focus on Expanding Uses of Cord Blood Stem Cells WALTHAM, Mass.–PerkinElmer, Inc., a global leader in Health Sciences and Photonics, today announced the creation of the ViaCord Research Institute™ (VRI™) aimed at investigating new potential future uses of umbilical cord blood-derived stem […]
Sense Proteomic spun out of Procognia Ltd by Apax and its management team Maidenhead, UK: June 4, 2008, Sense Proteomic Ltd. today announced its spin out and its creation as a biomarker discovery company. It will now be focussing on using its proprietary protein array platform to discover novel panels of auto-antibody biomarkers in cancer […]
BOSTON, MA., (30 May, 2008) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced its new Thermo Scientific Cell Culture Excellence™ program. Recognizing the importance of cell culture and its role in key research areas such as functional biology, disease studies, and cell-based drug discovery, Thermo Fisher Scientific has brought together […]
Dow Nucleic Acids Medicines Business Assets Acquired SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE:A – News) today announced the expansion of its nucleic acid active pharmaceutical ingredient (API) manufacturing facility in Boulder, Colo. Agilent’s Nucleic Acids Solutions Division is adding large-scale nucleic acid synthesis, purification and drying capacity that will come on stream by the end […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
